USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
AuraSense, LLC
Address:
8045 Lamon Avenue
Suite 410
Skokie, IL
Phone:
N/A
URL:
EIN:
264171829
DUNS:
831421958
Number of Employees:
5
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $300,000.00 2
SBIR Phase II $728,581.00 1
STTR Phase I $100,000.00 1
STTR Phase II $749,646.00 1

Award List:

Nano-Flares for the Intracellular Detection of miRNA in Living Cells

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$200,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Under the auspices of this small business innovation research (SBIR) grant, AuraSense LLC will develop a novel nanotechnology, Nano-flares , for the detection of low abundance microRNA (miR) species in living cells in real-time. MicroRNAs are short (~22… More

Modified Nanoparticles for Lipophilic Toxin Sequestration

Award Year / Program / Phase:
2011 / STTR / Phase I
Award Amount:
$100,000.00
Agency / Branch:
DOD / USAF
Principal Investigator:
Weston Daniel, Research Scientist – (847) 467-2874
Research Institution:
Northwestern University
RI Contact:
C. S. Thaxton
Abstract:
ABSTRACT: Mycotoxins are a class of weaponizable toxic secondary metabolites of molds and fungi. No treatments exist for exposure to these lipophilic poisons. AuraSense proposes to use lipid and protein modified gold nanoparticles to develop constructs for the sequestration of toxic lipophilic… More

Cell Regulation with Polyvalent Nanoparticles

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
DOD
Principal Investigator:
David Giljohann, Research Scientist – (847) 467-2874
Abstract:
ABSTRACT: Polyvalent nanoparticle constructs have unique properties that make them ideal for gene regulation applications, while overcoming many of the challenges which have prevented oligonucleotides from being developed into viable therapies. Specifically, AuraSense is developing constructs… More

Cell Regulation with Polyvalent Nanoparticles

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$728,581.00
Agency:
DOD
Principal Investigator:
David Giljohann, Chief Scientific Officer – (847) 467-2887
Abstract:
ABSTRACT: AuraSense is developing and commercializing NanoFlare technology as an enabling tool for detecting RNA levels in cells. Current methods for sensing of viral exposure require great amounts of virus particles to be present in blood, or extensive processing of blood to isolate virus-specific… More

Modified Nanoparticles for Lipophilic Toxin Sequestration

Award Year / Program / Phase:
2013 / STTR / Phase II
Award Amount:
$749,646.00
Agency:
DOD
Principal Investigator:
Weston Daniel, Research Scientist – (847) 673-1700
Research Institution:
Northwestern University
RI Contact:
Shad Thaxton
Abstract:
ABSTRACT: Mycotoxins are toxic secondary metabolites of molds and fungi, many of which are pathogenic to humans. In general, mycotoxins enter the body through the skin, digestive tract, or through respiration. Exposure to a few milligrams can be lethal. Mycotoxins have a high likelihood of … More